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Abstract
Paenibacillus larvae is the etiological agent of American Foulbrood (AFB) a
world-wide distributed devastating disease of the honey bee brood. Previous
comparative genome analysis and more recently, the elucidation of the bacterial
genome, provided evidence that this bacterium harbors putative functional
nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs)
and therefore, might produce nonribosomal peptides (NRPs) and polyketides
(PKs). Such biosynthesis products have been shown to display a wide-range of
biological activities such as antibacterial, antifungal or cytotoxic activity. Herein
we present an in silico analysis of the first NRPS/PKS hybrid of P. larvae and
we show the involvement of this cluster in the production of a compound
named paenilamicin (Pam). For the characterization of its in vitro and in vivo
bioactivity, a knock-out mutant strain lacking the production of Pam was con-
structed and subsequently compared to wild-type species. This led to the identi-
fication of Pam by mass spectrometry. Purified Pam-fractions showed not only
antibacterial but also antifungal and cytotoxic activities. The latter suggested a
direct effect of Pam on honey bee larval death which could, however, not be
corroborated in laboratory infection assays. Bee larvae infected with the non-
producing Pam strain showed no decrease in larval mortality, but a delay in the
onset of larval death. We propose that Pam, although not essential for larval
mortality, is a virulence factor of P. larvae influencing the time course of dis-
ease. These findings are not only of significance in elucidating and understand-
ing host–pathogen interactions but also within the context of the quest for new
compounds with antibiotic activity for drug development.
Introduction
Insect pathogenic bacteria have only recently been
recognized as a rich but poorly explored source of
structurally diverse secondary metabolites. Nonribosomal
peptides (NRPs) and polyketides (PKs) produced by
entomopathogens have been shown to have important bio-
logical roles during pathogenesis such as antagonism of
microbial competitors, motility, and contribution to viru-
lence. In addition, some of them might even have a future
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as pharmaceuticals (reviewed in Bode 2009). The emer-
gence of whole genome-sequencing projects and improved
genome mining techniques paved the way for the identifi-
cation of new NRP synthetase (NRPS) and PK synthase
(PKS) gene clusters. To date, known bacterial entomopath-
ogens producing secondary metabolites are for instance
Bacillus thuringiensis (Broderick et al. 2000), Pseudomonas
entomophila (Vallet-Gely et al. 2010), Serratia marcescens
(Li et al. 2005), and Xenorhabdus ssp. (Reimer et al. 2009).
Recently, Paenibacillus larvae has been added to the list of
secondary metabolite producing bacterial entomopatho-
gens (Fu¨nfhaus et al. 2009). Comparative genomics and
whole genome comparison within the species P. larvae
revealed the existence of several NRPS and NRPS/PKS gene
clusters (F€unfhaus et al. 2009; Djukic et al. 2014; Schild
et al. 2014) including an NRPS gene cluster leading to the
production of a novel nonribosomal peptide antibiotic,
sevadicin (Garcia-Gonzalez et al. 2014).
Paenibacillus larvae is the etiological agent of AFB, a
serious disease of the European honey bee (Apis mellifera)
larvae (Genersch et al. 2006). AFB is the most contagious
and destructive bacterial disease affecting honey bees.
Although only larvae are susceptible to and inevitably die
from the disease, AFB is able to kill entire colonies. Hence,
AFB is a notifiable epizootic in most countries and in the
case of an outbreak, burning of diseased colonies and con-
taminated hive material is usually considered the only
workable control measure. As a result, AFB leads to con-
siderable economic losses in apiculture. In addition, colony
losses due to AFB also compromise agricultural and natu-
ral ecosystems because of the indispensable role of honey
bees as pollinators of many fruit, crops, and wild flowers.
Despite the enormous impact of this disease, molecular
mechanisms of infection are not fully understood. To
date, we know that four different genotypes within the
species P. larvae exist named ERIC I to ERIC IV based on
the primers used for differentiation (Genersch et al.
2006). These genotypes not only differ in virulence (Gen-
ersch et al. 2005; Rauch et al. 2009) but also in their
genomic makeup (F€unfhaus et al. 2009; Djukic et al.
2014). All genotypes share the general steps in pathogene-
sis: Honey bee larvae become infected by ingesting spores,
which germinate in the midgut; vegetative P. larvae then
massively proliferate in the midgut, breach the peritrophic
membrane and the epithelium, and finally decompose the
larva to a ropy mass (Yue et al. 2008; Garcia-Gonzalez
and Genersch 2013). Recently, the first virulence factors
of P. larvae have been elucidated and were proved to be
genotype specific: P. larvae ERIC I expresses two AB tox-
ins, Plx1 and Plx2, missing in P. larvae ERIC II (F€unfhaus
et al. 2013) whereas the S-layer protein SplA, involved in
bacterial adhesion to the midgut epithelium, was shown
to be expressed only in P. larvae ERIC II (F€unfhaus and
Genersch 2012; Poppinga et al. 2012). The relevance of
secondary metabolites like sevadicin (Garcia-Gonzalez
et al. 2014) during pathogenesis of P. larvae infections
still remains elusive.
NRPs and PKs are secondary metabolites synthesized
by dedicated complex multimodular biosynthetic machin-
eries termed nonribosomal peptide synthetases (NRPSs)
and polyketide synthases (PKSs). Each module consists of
at least three domains responsible for a specific catalytic
reaction in the incorporation of an amino acid (NRPS)
or malonyl coenzyme A (PKS). These modular enzyme
machineries sequentially activate and condense specific
amino acids or acyl units. The modules of the megaen-
zymes of the NRPS-type (reviewed in Finking and
Marahiel 2004) commonly consist of the following
domains: The adenylation (A) domain of an NRPS specif-
ically binds and activates an amino acid by transforming
it into an amino acyl adenylate. The thiolation (T)
domain covalently binds the activated amino acid to the
module via a phosphopantetheinyl arm. The condensation
(C) domain catalyzes the formation of a peptide bond
between two amino acids of neighbored modules. The
terminal module consists of an additional thioesterase
(TE) domain which releases the peptide from the NRPS.
It may occur that NRPSs contain additional domains for
further peptide modification. An important representative
of such a domain is the epimerization (E) domain which
catalyzes the inversion of the stereocenter of the activated
L-amino acid into its D-amino acid enantiomer.
Likewise the modules of type I PKSs consist of at least
three core domains (reviewed in Hill 2006): the acyltrans-
ferase (AT) domain binds an appropriate acyl unit and
transfers it into the acyl carrier protein (ACP) domain.
The elongation step is performed by the ketosynthetase
(KS) domain which catalyzes the formation of a C–C
bond via Claisen condensation with the acyl unit of the
next module. Optionally, the present domains for further
tailoring of the substrates are ketoreductase (KR) domains
that catalyse the reduction of the b-keto group to a
b-hydroxy group. A fully saturated acyl backbone addi-
tionally requires the reductive action of dehydratase
(DH), and enoyl reductase (ER) domains.
Here, we report on the identification, isolation, and
biological characterization of a novel NRP/PK hybrid,
named paenilamicin (Pam), produced by P. larvae. By
means of construction of a gene-inactivation mutant fol-
lowed by mass spectrometric analysis, we were able to
link functionality of the pam gene cluster responsible for
Pam production and antibiotic activity. Further in vitro
and in vivo assays corroborated the antibacterial, antifun-
gal and cytotoxic activities of this metabolite. Moreover,
in vivo functional analyses suggested that Pam might act
as a putative virulence factor in AFB pathogenesis. The
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study of antibiotic substances produced by the entomo-
pathogen P. larvae is of outstanding interest because of
both, the identification of a novel bioactive NRPS/PKS
hybrid and the characterization of the biological function
of this substance.
Materials and Methods
Bacterial strains and culture conditions
Wild-type P. larvae bacteria (DSM25430; ERIC II (Gener-
sch et al. 2005)) were cultivated either in MYPGP liquid
broth (Dingman and Stahly 1983) or on Columbia sheep
blood agar (CSA) plates at 37°C as previously described
(Genersch and Otten 2003; Neuendorf et al. 2004). Gene
inactivation mutants of P. larvae were cultivated on
MYPGP-agar plates supplemented with 5 lg/mL chloram-
phenicol for selection and incubated at 37°C for 2–3 days
as previously described (Poppinga et al. 2012).
Paenibacillus alvei, Bacillus subtilis, Bacillus licheniformis,
Bacillus megaterium, and Saccharomyces cerevisiae were
obtained from the DSMZ (Deutsche Sammlung von
Mikroorganismen und Zellkulturen GmbH, Braunschweig,
Germany). Pichia pastoris yDT39 was a generous gift from
Prof. Budisa (Technische Universit€at, Berlin, Germany)
and Fusarium oxysporum ETH1536/9 was obtained from
the Centraalbureau voor Schimmelcultures (Utrecht, the
Netherlands). These strains were used for testing the anti-
bacterial activity of P. larvae culture supernatants or puri-
fied Pam. All strains were grown in LB (Luria Bertani),
MYPGP, YPD or FCM media (broth or agar plates).
Paenibacillus larvae spore suspensions were generated
by resuspending about 100 colonies in 300 lL brain heart
infusion (BHI) broth to inoculate the liquid part of CSA
slants. These were incubated at 37°C for 10 days. Spore
concentrations were determined by cultivating serial dilu-
tions as already described (Genersch and Otten 2003;
Neuendorf et al. 2004).
Escherichia coli DH5a cells (Invitrogen, Karlsruhe, Ger-
many) transformed with the plasmid pTT_pamA (see
below) were cultivated in selective LB media (agar and
broth) supplemented with 30 lg/mL chloramphenicol. Plas-
mid DNA was prepared following the manufacturer’s proto-
cols (QIAprep Spin Miniprep kit; Qiagen, Hilden,
Germany). Concentration and purity of the plasmid prepa-
rations were analyzed by photometric analysis (Nanodrop;
Peqlab, Erlangen, Germany) and agarose gel electrophoresis.
Paenibacillus larvae cultivation for
secondary metabolite production
Paenibacillus larvae was cultivated as follows: bacteria
were grown on CSA plates at 37°C for 2–3 days. A
preculture of 10 mL MYPGP medium was inoculated
with a single colony and grown overnight. A 50 mL of
MYPGP broth was inoculated with the preculture to
reach a final (calculated) OD600 of 0.001. This main cul-
ture was incubated at 30°C with gentle shaking (80 rpm,
Thermoshake; Gerhardt, Bonn, Germany) for 72 h. Cul-
tures were centrifuged for 10 min at 4°C with 3200 g and
supernatants were stored at 20°C until further use.
Agar diffusion assay for antibacterial
activity
To test the antibiotic activity of P. larvae supernatants,
P. alvei, B. subtilis, B. licheniformis and B. megaterium were
used as bacterial indicator strains and S. cerevisiae, Pichia
pastoris, and Fusarium oxysporum as fungal indicator
strains. The activity against P. alvei, B. subtilis, B. licheni-
formis, B. megaterium, and S. cerevisiae was tested as fol-
lows. A preculture was grown in 5 mL of the
correspondent broth (LB or MYPGP) and cultured over-
night at 37°C with gentle shaking. A 10 mL of the corre-
spondent broth was inoculated with 500 lL of this
preculture and cultivated at 37°C with gentle shaking for
5 h. Subsequently, the OD600 of the cultures (typically
between 0.5 and 0.7) was determined. A 40 mL of molten,
37°C warm LB or MYPGP agar was inoculated to reach a
final (calculated) OD600 of 0.05 and poured on Petri
plates, while 20 lL of the test substrate (P. larvae superna-
tants or purified Pam) was dispensed on a filter disk and
dried at RT. Subsequently, the disks were carefully placed
on the agar. Alternatively, holes of 6 mm in diameter were
made into the agar and filled with 40 lL of the tested sub-
stance. The plates were incubated at 37°C overnight. Clear
zones around the filter disks or the holes were considered
indicative of growth inhibition. P. pastoris yDT39 was
grown in 5 mL YPD medium at 30°C and 200 rpm until
reaching OD600 of around 0.8–0.9. 200 lL of this culture
were plated on YPD agar plates (10 mL per plate). Plates
were incubated at 30°C overnight. F. oxysporum ETH
1536/9 was grown in 5 mL FCM medium at 27°C and
115 rpm for 48 h. FCM agar plates for bioactivity tests
were made the same way as described for P. pastoris above.
The agar plates were incubated at 27°C for 2–3 days.
Sequence analysis
The genome sequence of Paenibacillus larvae (P. larvae
DSM25430 (Djukic et al. 2014), NCBI Reference
Sequence NC_023134.1) was screened for polyketide syn-
thase (PKS) – and nonribosomal peptide synthetase
(NRPS) – coding sequences. This analysis revealed the
occurrence of nine genes consisting of five NRPSs, two
PKSs, and two NRPS/PKS hybrid genes (NC_023134.1,
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position 1729923–1788675). Sequence similarity searches
were performed using BLASTX and BLASTP at the NCBI
website (Altschul et al. 1997). Domain organization,
extraction of binding pocket signatures and substrate
specificity prediction were analyzed by using in silico
tools: NRPSpredictor2 (Rausch et al. 2005; R€ottig et al.
2011), PKS/NRPS analysis (Bachmann and Ravel 2009),
and SBSPKS (Anand et al. 2010).
Construction of a P. larvae gene inactivation
mutant (knock-out strain)
The gene pamA (Gene ID: 18058116) from the pam gene
cluster was disrupted in the genome of P. larvae
DSM25430 via a recently described strategy (Zarschler
et al. 2009). Vector pTT_wsfA243 (Zarschler et al. 2010)
was used for constructing a targetron vector for targeted
group II intron insertion at position 1080 from the start
codon of pamA of the pam gene cluster. Retargeting of
the LI.LtrB targetron of vector pTT_wsfA243 prior to
transformation into P. larvae was performed following
the manufacturer’s protocol and essentially as already
described for disruption of the P. larvae S-layer gene splA
(Poppinga et al. 2012). In brief, a computer algorithm
provided by the manufacturer (http://www.sigma-genosys.
com/targetron) identified potential insertion sites for the
intron into pamA open reading frames and designed suit-
able PCR primers (Table 1) for the modification of the
intron RNA. The algorithm predicted a high insertion
efficiency for the position 1080 in the gene and designed
corresponding PCR primers. These primers were used for
modification of the LI.LtrB targetron to generate the new
vector pTT_pamA, respectively, which were subsequently
transformed into E. coli DH5a cells for plasmid replica-
tion and preparation. The targeted sequence for intron
insertion was unique inside the DSM25430 genome,
assuring the specificity of gene inactivation.
For generation of a P. larvae gene inactivation mutant,
electrocompetent P. larvae DSM25430 cells (ERIC II)
were prepared as described (Murray and Aronstein 2008)
and 1 lg of plasmid pTT_pamA was transformed by
electroporation as recently established (Poppinga and
Genersch 2012). Cells were regenerated in MYPGP broth
for 16 h, plated on MYPGP-agar containing 5 lg/mL
chloramphenicol and incubated for 3 days. Positive clones
were identified by PCR analysis using primers flanking
the intron insertion positions of the targeted ORF: 948
and 1276 (Table 1, Fig. 1A), leading to the construction
of the strain DSM25430 DpamA. Germination, growth in
liquid broth, and sporulation of P. larvae DSM25430
DpamA was tested and did not significantly differ from
the parent wild-type strain (Fig. 1B; two-way ANOVA;
P = 0.607) thus ruling out that the outcome of the expo-
sure bioassays is influenced by unknown side effects of
the knock-out strategy on relevant features of the bacteria
as also already described for other P. larvae knock-out
mutants generated with the targetron strategy (Poppinga
et al. 2012; F€unfhaus et al. 2013).
Liquid chromatography-electrospray
ionization-mass spectrometry analytics
Polypropylene columns (1 mL) (Qiagen) were filled with
Amberlite XAD-16 adsorption beads (Sigma, St. Louis,
MO) (1.5 g), and used for subsequent chromatographic
fractionation. Thus, prepared columns were then equili-
brated by flushing with three column volumes (CVs) of
distilled water. Frozen supernatants of P. larvae cultures
were thawed, and the column was loaded with superna-
tant. A step gradient was applied using 1 CV of distilled
water followed by aqueous methanol of decreasing polar-
ity (1 CV each in 10% steps: 10%, 20%, 30%; etc. 100%).
Eluates were tested for bioactivity against B. megaterium.
Chromatographic fractions from P. larvae wild-type
showing bioactivity and the corresponding fractions from
P. larvae gene inactivation mutant were pooled and dried
in vacuo. For LC-ESI-MS analytics, the extracts were
resolved in 5 mL 10% aqueous acetonitrile + 0.1% formic
acid and a portion of 2 lL was injected into the HPLC
(high-pressure liquid chromatography) column.
LC-ESI-MS analytics were performed using an Agilent
6410 Triple Quadrupole LC/MS system in MS2-scan
mode coupled to an UHPLC 1290 Infinity-Series (Agilent
Technologies, Waldbronn, Germany). As a column, an
Eclipse Plus C18 B 1.5 lm, 2.1 9 50 mm (Grace; Grace
GmbH & Co KG, Worms, Germany) was used for separa-
tion. Samples of the same concentration were analyzed by
linear gradient elution using H2O + 0.1% formic acid as
Table 1. Primers used in this study.
Primer name Primer sequences (50–30) Used for
IBS_cltIII_pksA AAAAAAGCTTATAATTATCCTTATCCGGCGTCGCAGTGCGCCCAGATAGGGTG creation of pamA knock-out
EBS1d_cltIII_pksA CAGATTGTACAAATGTGGTGATAACAGATAAGTCGTCGCAGGTAACTTACCTTTCTTTGT
EBS2_cltIII_pksA TGAACGCAAGTTTCTAATTTCGGTTCCGGATCGATAGAGGAAAGTGTCT
PKSA_F GGCACGAGCATGGGTGATCCG sequencing; verification of pamA
knock-outPKSA_R CGTGGACATTTGTCCCGCCCA
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solvent A and acetonitrile + 0.1% formic acid as solvent
B. The gradient was from 5% to 100% solvent B in 6 min
with a 2-min isocratic elution at 100% for solvent B.
Bioassay-guided isolation of Pam for
bioactivity assays
Small-scale purification was performed by a step-wise
fractionation protocol. Bioactive fractions against
B. megaterium XAD-16 fractions were submitted to
Sephadex LH-20 column (25 9 1000 mm, filled with
492 g Sephadex LH-20 media, GE Healthcare, Uppsala,
Sweden). The injection volume was 5 mL with a flow rate
of 0.5 mL/min. 1.2 CVs were fractionated isocratically
with 100% H2O with a fraction size of 2 mL. Antibioti-
cally active fractions were pooled and dried in vacuo and
purified subsequently by using a Reveleris Flash Car-
tridge (Grace; Grace GmbH & Co KG, Worms, Germany)
filled with 4 g C18 reversed phase resin coupled to a Rev-
eleris X2 Flash System (Grace; Grace GmbH & Co KG).
The separation was accomplished by linear gradient elu-
tion using H2O + 0.1% formic acid as solvent A and
methanol + 0.1% formic acid as solvent B. The gradient
was from 3% to 15% solvent B in 20 min, followed by a
5-min gradient to 100% B ending at 100% B isocratic for
5 min at a flow rate of 18 mL/min.
Bioactive fractions were pooled, concentrated and puri-
fied subsequently by using a Grace HPLC column
(250 9 20 mm) filled with 10 lm GROM-Sil 120 ODS-5
ST coupled to an Agilent 1100 HPLC system (Agilent
Technologies) with a multi wavelength ultraviolet detector
(MWD). The separation was accomplished by linear gra-
dient elution using H2O + 0.1% formic acid as solvent A
and methanol + 0.1% formic acid as solvent B. The gra-
dient was from 3% to 15% solvent B in 45 min, followed
by a 5-min gradient to 100% B ending at 100% B isocrat-
ic for 5 min at a flow rate of 10 mL/min.
Subsequently, bioactive fractions were loaded onto a
HPLC column (150 9 4.0 mm) filled with 5 lm, 12 nm
YMC-Pack C-8 (Octyl) (YMC Europe GmbH, Dinslaken,
Germany) coupled to an Agilent 1100 HPLC system (Agi-
lent Technologies) with a DAD UV detector. The samples
were separated by linear gradient elution using
H2O + 0.1% formic acid as solvent A and acetoni-
trile + 0.1% formic acid as solvent B at a flow rate of
1.5 mL/min. The gradient was from 3% to 20% for sol-
vent B in 8 min with a 2-min hold at 20% for solvent B
followed by a 2-min gradient to 100% B ending at 100%
B isocratic for 5 min. Pam-containing fractions (mass
spectrometric control) were used for bioactivity assays.
High-resolution-LC-ESI-MS analytics
For the analysis of pure Pam an LTQ Orbitrap XL mass
spectrometer (Thermo Scientific, Bremen, Germany) cou-
pled to an Agilent 1260 HPLC system (Agilent Technolo-
gies) was used. A Grom-Sil ODS-4 HR 3 lm,
50 9 2.0 mm column (Grace; Grace GmbH & Co KG)
was used for separation. The sample was analyzed by lin-
ear gradient elution using H2O + 0.1% formic acid as
solvent A and acetonitrile + 0.1% formic acid as solvent
B. The elution started with an initial hold at 5% B for
1.6 min followed by an increase of solvent B to 100% in
7.9 min with a hold at 100% for 2.5 min.
Cell toxicity assays
Cytotoxicity in vitro tests were performed using the com-
mercial available cell line: BTI-Tn-5B1-4 cells (generous gift
(A)
(B)
Figure 1. Determination of successful knock-out construction and
growth analysis of knockout mutant. (A) PCR analysis of the constructed
knock-out mutant DSM25430 DpamA, revealed successful intron
insertion. Primers flanking the insertion sites in the pamA gene in the
wild-type strain DSM25430 wt, amplified a fragment that was 915 bp
smaller than the fragment amplified from DSM25430DpamA because
of intron insertion. (B) Growth of DSM25430 wt and DSM25430
DpamA was analyzed with three biological and three technical
replicates each. No significant difference in growth could be observed
(two-way ANOVA, P = 0.607). PCR, polymerase chain reaction.
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from Dr. Holger H€ubner from the Friedrich-Alexander-
Universit€at Erlangen-N€urnberg, Germany). The cells were
maintained in 75 cm2 cell culture flasks (Roth) filled with
20 mL of serum-free Sf 900II medium (Lonza, Walkersville,
MD, USA) and cultivated at 27°C in a cooling incubator.
Cells were passaged once a week adjusting its initial concen-
tration to 2E + 05 cells per mL using a counting chamber.
2E + 04 cells (100 lL) were seeded in each well of a
96-well microtiter plate and incubated at 27°C for 24 h
to allow cell adherence. Microtiter plates were centrifuged
with 220g for 15 min and medium was removed and
replaced with 100 lL medium plus the different samples:
Pam isolated from the supernatant of DSM25430 wt was
resuspended (1:100) in 100 lL SF 900 II medium with a
250 lg mL1 penicillin/streptomycin premix. Controls
were performed as follows: SF 900 II medium served as a
blank, HPLC solvent (1:100 diluted 5% acetoni-
trile + 0.1% formic acid) served as a negative control,
and 10 lL of lysis buffer (99.4 mL DMSO, 0.6 mL acetic
acid and 10% SDS w/v) served as a positive control for cell
toxicity. After 40 h of incubation at 33°C, plates were
centrifuged (220 g for 15 min) and the medium was
discarded. Subsequently, 100 lL of fresh MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid) solu-
tion (0.5 mg/mL in SF 900 II medium) was added to the
cells and incubated at 27°C for 3 h. Microtiter plates were
centrifuged again at 220g for 10 min and the supernatant
was carefully aspirated without damaging the cell pellet.
To disrupt the cells and liberate formazan, 100 lL lysis
buffer (99.4% DMSO mL, 0.6% acetic acid, 10% SDS
w/v) were added and the plate was incubated for 5 min
at 300 rpm on a vibrate platform shaker (Titramax 1000;
Heidolph, Schwabach, Germany) at room temperature.
The OD corresponding to cell-absorbed formazan, and
thus to cell vitality after the treatment was analyzed with
the SynergyHT ELISA reader (BioTek, Bad Friedrichshall,
Germany) using 595 nm excitation wavelength.
Infection assays
To analyze the functional role of Pam during pathogene-
sis, an exposure bioassay was performed as described by
Genersch et al. (2005 and) Genersch et al. (2006). Prepa-
ration of spore suspension for infection assays was per-
formed as previously described (Genersch et al. 2005,
2006; Rauch et al. 2009; Poppinga et al. 2012; F€unfhaus
et al. 2013). Spore concentrations were calculated by plat-
ing out serial dilutions on CSA agar plates and counting
colony forming units (CFUs). Spore suspensions with
equal concentrations of CFUs were prepared for both
wild-type and knock-out. Larvae of first instar were
infected with P. larvae ERIC II wild-type (DSM25430)
and the Pam deficient knock-out mutant (DSM25430
DpamA) by adding corresponding spores in a final con-
centration of 500 cfu/mL (about LC100) to the larval diet
to ensure that infection of larvae was initiated by the
same number of vegetative P. larvae for wild-type and
knock-out bacteria. Control larvae were fed with normal
larval diet, consisting of 66% royal jelly (v/v), 3.3% glu-
cose (w/v) and 3.3% fructose (w/v). After 24 h, larvae
were transferred to fresh food daily and monitored for
15 days. Dead larvae were removed, streaked out on CSA,
incubated at 37°C for 2–3 days, and checked for AFB
phenotypically and by PCR (Kilwinski et al. 2004). Only
larvae that died of AFB infected by P. larvae ERIC II
(DSM25430 wt) or by the Pam-deficient knock-out
(DSM25430 DpamA) mutant, respectively, were consid-
ered for statistical calculations. Knock-out stability was
proved by PCR with the gene-specific primer pair
(Table 1) PKSA_F and PKSA_R, flanking the intron
insertion site 1080. PCR amplicons were analyzed by gel
electrophoresis on a 1% agarose gel, stained with ethidi-
um bromide and visualized by UV light.
Total mortality was depicted as mean values  SD
and statistically analyzed by Student’s t-test. Survival
curves were plotted and two-way ANOVA was used to
calculate significant differences. Infection assays for
DSM25430 wt, DSM25430 DpamA mutant and control
larvae were carried out three times with 30 replicates
each, statistical analysis was performed using GraphPad
Prism 6 software.
Results and Discussion
Genomic organization of the Pam NRPS/PKS
hybrid gene cluster
The complete genome of Paenibacillus larvae DSM25430
(ERIC II) has been sequenced (NCBI Reference Sequence
NC_023134.1) and it has been shown to harbor several
NRPS and NRPS/PKS hybrid clusters (Djukic et al. 2014).
One of these clusters codes for a trimodular NRPS syn-
thesising the tripeptide sevacidin (Garcia-Gonzalez et al.
2014). Further analysis now revealed a gene cluster coding
for a mixed NRPS/PKS hybrid gene cluster termed pam
cluster, with the compound Pam as its correspondent bio-
synthesis product. The genomic organization of the pam
cluster revealed a size of ~60 kb comprising five NRPS
genes, two PKS genes, and two NRPS/PKS hybrid genes
(gene locus tags ERIC2_c18040 – ERIC2 _c180170)
(Fig. 2, Table S1). The hybrid NRPS/PKS coding genes
were assigned as pamA and pamB. Each of these hybrids
contains an A domain (A1 and A2) for activation of cor-
responding amino acid substrates. The genes pamC,
pamD, pamE, pamH, and pamN code for NRPSs whereas
pamF and pamG code for PKSs.
ª 2014 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd. 647
E. Garcia-Gonzalez et al. P. larvae Nonribosomal Polyketide-Peptide Hybrid
BLAST analysis (Altschul et al. 1990, 1997) did not
reveal any similarity to known NRPS/PKS gene clusters.
In order to gain insight into the cognate amino acid sub-
strates, we used several software tools and databases
which allow predicting of substrate specificity of amino
acid-activating adenylation domains (A domains) of
NRPSs. NRPSpredictor2 predicts A-domain substrate
specificity based on sequence and structural information
about the active site of the domain (http://nrps.informa-
tik.uni-tuebingen.de/) (Rausch et al. 2005; R€ottig et al.
2011). This program recognized the A2, A5, and A8
domains as well conserved and predicted the activation
of Asn (90%), Ser (100%), and Asn (100%), respectively
(Table 2). The other A domains of the pam cluster were
less well conserved and, hence, provided only poor pre-
dictions: Lys (60%), Phe (50%), Asp (70%), Phe (50%),
and Gly (70%) were predicted to be recruited by the A1,
A3, A4, A6, and A7 domains, respectively (Table 2).
Modules NRPS4 and NRPS8 contain an additional
epimerization domain for the stereochemical conversion
of the activated L-amino acid into its D-amino acid enan-
tiomer, suggesting D-Asp and D-Asn as constituents of
Pam, respectively. Closer inspection of the four PKS
modules revealed, next to a standard set of ketosynthase
(KS), AT and ACP, that they each contains a KR domain,
indicating the transformation of a ß-carbonyl into a
ß-hydroxy group. The pamG gene codes for a PKS with a
C-terminal C domain. While the predictor software was
unable to predict the function of the second domain, a
BLAST comparison of the domain sequence suggested an
acyltransferase domain. We next used the NRPS-PKS tool
of the SBSPKS software (http://www.nii.ac.in/~pksdb/
sbspks/master.html) which allows identifying various cat-
alytic domains in the sequence of Type I PKS proteins
and comparing them with experimentally characterized
PKS/NRPS clusters cataloged in the backend databases of
SBSPKS (Anand et al. 2010). Analysis of the pam gene
cluster using this software predicted two additional
domains in NRPS module 3 and NRPS module 6, sug-
gesting an N-methylation of the incorporated amino
acids, presumably Phe (Table 2). Finally, we used NRPS/
PKS analysis software (http://nrps.igs.umaryland.edu/
nrps/2metdb), which has been designed for the prediction
of microbial secondary metabolic pathways from DNA
sequence data of gene clusters leading to the production
of modular PKs and nonribosomally encoded peptides
(Bachmann and Ravel 2009). Comparison of the results
obtained by all three software tools (SBSPKS, NRPSpre-
dictor2 and NRPS/PKS analysis) for the A domain speci-
ficity verified recruitment of Asn by A2 (NRPSpredictor
2 and SBSPKS), Ser by A5 (NRPSpredictor, SBSPKS,
Asn/Asx
pamA pamB pamC pamD pamE
pamF pamG pamH pamI pamJ pamKLM pamN
5SPRN4SPRN3SPRN2SPRN1SPRN PKS 1 PKS 2
8SPRN7SPRN6SPRNPKS 3 PKS 4
Ser/Phe Hpg/Gly































Figure 2. Domain organization derived from the pam secondary metabolite gene cluster in the genome of Paenibacillus larvae DSM25430. In the
genome of P. larvae DSM25430 (NCBI Reference Sequence NC_023134.1) an NRPS/PKS hybrid gene cluster could be identified. The gene cluster
of the putative NRP/PK hybrid paenilamicin (pam cluster) consisted of five NRPS, two PKS, and two NRPS/PKS hybrid genes. A, adenylation
domain; C, condensation domain; T, thiolation domain; E, epimerization domain; MT, N-methyl transferase; KS, ketosynthetase; AT,
acetyltransferase; KR, ketoreductase, and ACP, acyl carrier protein. Domain prediction was performed using SBSPKS (Anand et al. 2010). NRPSs,
nonribosomal peptide synthetases; PKSs, polyketide synthases.
Table 2. In silico prediction of A-domain specificity.
A domain NRPSpredictor2 SBSPKS PKS/NRPS analysis
1 Lys D-Glu NO HIT
2 Asn Asn NO HIT
3 Phe Ser NO HIT
4 Asp D-Glu Asp/hAsp/Glu
5 Ser Ser Ser
6 Phe Ser NO HIT
7 Gly Hpg Hpg
8 Asn Asn Asx
PKS, polyketide synthases; NRPS, nonribosomal peptide synthetases.
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NRPS/PKS analysis), 4-hydroxyphenylglycine (Hpg) by
A7 (PKS/NRPS analysis, SBSPKS), and Asn (SBSPKS,
NRPSpredictor2) or Asx (PKS/NRPS analysis) by A8
(Table 2). Between pamH and pamN, five genes (pamI,
pamJ, pamK, pamL, pamM) are located (Fig. 2) that were
analyzed by BLAST. PamI and pamL could not be identi-
fied (hypothetical proteins) whereas pamJ, pamK, and
pamM were identified and annotated as cyclic peptide
transporter, 3-hydroxy-CoA dehydrogenase, and tran-
scription antiterminator-like protein NusG, respectively
(Djukic et al. 2014).
Recently, it was noted that the here described 30-end of
the Pam biosynthesis gene cluster comprising pamH to
pamN and the xenocoumacin (XCN) biosynthesis gene
cluster identified in Xenorhabdus nematophila contain
homologous genes (Reimer et al. 2011). The P. larvae
NRPS7 (PamH) was reported to recruit Hpg confirming
our prediction (see above) and the NRPS PamN was
shown to be homologous to the starting module XcnA of
the XCN biosynthesis gene cluster (Reimer et al. 2011) as
were corresponding modules in the biosynthesis gene
clusters for amicoumacin (B. pumilus), zwittermicin
(B. thuringiensis), colibactin (E. coli), and other similar
NRPS/PKS clusters with unknown products (Reimer et al.
2011). All of these starting modules are predicted to be
specific to Asn or Asx (Reimer et al. 2011). The XCN
biosynthesis gene cluster also harbors the gene xcnG
which was originally described as encoding a peptide
transporter involved in the resistance mechanism (Reimer
et al. 2009). However, most recent studies revealed that
XcnG has a peptidase function which is necessary for pro-
drug activation (Reimer et al. 2011). The X. nematophila
peptidase XcnG was shown to be a homolog of PamJ
(Reimer et al. 2011) suggesting that pamJ might be a pep-
tidase gene rather than a peptide transporter gene. How-
ever, peptidase function of PamJ needs to be confirmed
experimentally especially since considerable structural dif-
ferences between XcnG and PamJ exist. Reimer and co-
workers proposed two different domain architecture types
for these prodrug-activating peptidases. Type I with XcnG
as the model peptidase comprises a signal peptide fol-
lowed by a peptidase domain and three C-terminal trans-
membrane helices. In contrast, P. larvae PamJ has type II
domain architecture with nine transmembrane helices fol-
lowed by an ABC transporter domain presumably located
in the cytoplasm (Reimer et al. 2011). Therefore, an addi-
tional transport function of PamJ is likely but needs to be
confirmed experimentally.
Xenocoumacins are produced by bacteria of the genus
Xenorhabdus. These bacteria live in symbiosis with nema-
todes of the genus Steinernema which infect and kill insects.
The proposed role of XCN in this symbiotic entomopatho-
genic complex is either to help killing the insect or to help
killing the bacteria living inside the insect gut and compet-
ing with Xenorhabdus for food (Reimer et al. 2011). Inter-
estingly, the same roles can be discussed for Pam. It might
either act as an antibiotic killing bacterial competitors of P.
larvae in the honey bee larval gut or it might act as a toxin
helping P. larvae to kill the honey bee larvae. To address
these questions, we functionally analyzed Pam.
Paenilamicin is a nonribosomal peptide
antibiotic
Paenibacillus larvae have been reported to produce anti-
bacterial activity against different Gram-negative and
Gram-positive bacteria including B. subtilis and P. alvei
(Holst 1945). Nonribosomally synthesized peptide-polyke-
tide hybrids like Pam often have antibiotic activity. In
order to elucidate the contribution of the functional pam
gene cluster and hence its biosynthetic product to the
antibiotic activity of P. larvae, a knock-out mutant of P.
larvae (DSM25430 ΔpamA) was generated, which was
interrupted in the NRPS/PKS gene pamA. Subsequently,
culture supernatants of wild-type P. larvae (DSM25430
wt) and mutant P. larvae lacking Pam production
(DSM25430 ΔpamA) were tested for absence or presence
of inhibitory activity against various bacteria (P. alvei, B.
subtilis, B. licheniformis, and B. megaterium) and fungi
(Sacchoaromyces cerevisiae, Pichia pastoris, and Fusarium
oxysporum) selected because of their potential association
with honey bees (Bailey 1963; Gilliam et al. 1974; Gilliam
and Prest 1987; Snowdon and Cliver 1996; Gilliam 1997;
Yoder et al. 2013). Culture supernatants of the wild-type
P. larvae strain inhibited growth of all tested microorgan-
isms although differences in inhibitory potential were evi-
dent (Fig. 3). In contrast, culture supernatants of the
DSM25430 ΔpamA mutant did not show any inhibitory
activity. These results clearly linked integrity and thus
functionality of the pam gene cluster to antibacterial/anti-
fungal activity of P. larvae culture supernatants. So far we
only tested some of the microorganisms P. larvae might
encounter when infecting honey bee larvae. Once the lar-
val microbiome is fully analyzed and, hence the potential
competitors of P. larvae in the larval gut and the dead
larvae are known, it will be of special interest to identify
the target organism(s) of Pam. It will also be interesting
to explore the potential of Pam in anti-infective therapy
by elucidating the spectrum of medically relevant micro-
organisms inhibited by this antibiotic.
Identification and purification of Pam
In order to further characterize the putative biosynthetic
product of the pam gene cluster, a comparative metabolic
profiling using HPLC mass spectrometry was employed.
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Direct HPLC-ESI-MS analysis of culture filtrates of
P. larvae wild-type and P. larvae ΔpamA did not render any
mass peaks which could be assigned to Pam or derivatives
(Fig. S1). This finding could be attributed to signal
suppression in mass spectrometry by high matrix back-
ground of the culture filtrate. Therefore, we performed a
polarity-based fractionation of whole P. larvae DSM25430
ΔpamA supernatants and of the corresponding parent wild-
type strain P. larvae DSM25430 by XAD-16 chromatogra-
phy. Briefly, 50 mL of whole supernatants of the wild-type
and the pamA knock-out were incubated with XAD-16 res-
ins. Fractionation of the supernatants was accomplished
with increasing concentrations of methanol (0–100%) as
eluent. Subsequently, antibacterial activity of the eluted
fractions was tested against B. megaterium. The DSM25430
wt 90% methanol fraction, that was highly active against
B. megaterium, and the corresponding DSM25430 ΔpamA
90% fraction that showed no antibiotic activity were chosen
for comparative metabolic profiling using reversed-phase
HPLC electrospray ionization mass spectrometry (RP-LC-
ESI-MS). Careful comparison of the obtained spectra
indicated a compound eluting at Rt = 0.6 min that was
absent in the corresponding fraction of the mutant strain
(Fig. 4A). By HPLC-ESI mass spectrometry two
singly-charged ion peaks with molecular masses of
[M+H]+ = 1009.6 and 1037.6 Da could be identified in the
90% methanol fractions of the P. larvae wild-type strain
that were absent in the 90% methanol fractions of the
DSM25430 DpamA strain (Fig. 4B). Due to the gene inacti-
vation experiments of the pam gene cluster we could unam-
biguously assign these peaks as products of the NRPS/PKS
machinery that is encoded by the pam gene cluster.
To verify our assumption that the identified peaks are


























Figure 3. Contribution of paenilamicin to the antibacterial and
antifungal activity of P. larvae culture supernatants. P. larvae ERIC II
wild-type strain DSM25430 and mutant strain DSM25430 ΔpamA
lacking paenilamicin production were grown in MYPGP medium
at 30°C. Activity of culture supernatants against different
bacteria (Paenibacillus alvei, Bacillus subtilis, B. licheniformis, and B.
megaterium) and fungi (Saccharomyces cerevisiae, Pichia pastoris, and
Fusarium oxysporum) was tested by agar diffusion assays. Neg.
control: MYPGP medium.

































Figure 4. Identification of paenilamicin by HPLC-ESI-triple quadrupole
MS from P. larvae secretome after sample workup. (A) Comparison of
extracted ion chromatograms (EIC, m/z 519.0–519.5 corresponding to
twofold charge state (z = 2) of paenilamicins) of a 90% XAD-16
fraction from wild-type strain DSM25430 (black) with mutant strain
DSM25430 ΔpamA (red) (cultivation time 72 h). (B) Mass spectrum of
a fraction (90% XAD-16) of P. larvae DSM25430 wild-type. Molecular
masses of paenilamicins: [M+H]+ = 1009.6 Da and 1037.6 Da (elution
time 0.397–0.843 min). No corresponding peaks were found for the
mutant strain (data not shown). HPLC, high-pressure liquid
chromatography; MS, mass spectrometry.
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bioactivity-guided small-scale purification from 1 L
culture of P. larvae DSM25430 wt by a stepwise fraction-
ation protocol with B. megaterium as the indicator strain
(see Material and Methods). Fractions containing Pam
were collected from the semi-preparative C8 HPLC sepa-
ration and pooled. High sample purity was confirmed by
a single peak in the chromatogram (MS detection) and
high-quality MS data with little background (Fig. 5A and
B). Subsequent high-resolving HPLC-ESI Orbitrap-MS of
the pooled fractions showed that Pam consists of two
components ([M+H]+ = 1009.6718 and 1037.6780 Da;
Fig. 5B). Thus, the purified Pam mixture (~1.2 mg) was
used for further functional assays to characterizing
bioactivities.
Purified Pam has antibacterial, antifungal,
and cytotoxic activity
To further confirm the results obtained with P. larvae cul-
ture supernatants, we used purified Pam in agar diffusion
assays performed with B. megaterium, B. licheniformis,
P. alvei, P. pastoris, and F. oxysporum as bacterial and
fungal indicator strains, respectively. Halos around the
disk impregnated with 20 lL Pam (B. megaterium and
B. licheniformis) or the hole containing 40 lL Pam (P.
alvei, P. pastoris, and F. oxysporum) confirmed the results
obtained with culture supernatants and further substanti-
ated that Pam has antibacterial and antifungal activity
(Fig. 6A). This activity was concentration dependent as
revealed by an increased inhibition of B. megaterium and
F. oxysporum when increasing concentrations of purified
Pam (0.3–20.0 and 5.0–40.0 lg, respectively) were tested
(Fig. 6B). Some secondary peptide metabolites also have
cytotoxic activity. In order to further converge to the
in vivo function of Pam we, therefore, investigated its
putative cytotoxicity on insect cells by using the insect cell
line Tn5 derived from Trichoplusia ni (Lepidotera). Cell
vitality was determined via MTT test for Tn5 cells incu-
bated in cell culture medium alone (SF 900 II medium)
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Figure 5. HR-MS analysis of purified paenilamicin. (A) Total ion chromatogram (TIC) of purified paenilamicin. (B) Corresponding HR mass
spectrum (1.26–2.37 min) showing both paenilamicin derivatives with different charge states. m/z 391.2838 is a compound also present in blank
measurements. HR, high resolution; MS, mass spectrometry.
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vent (1:100 diluted 5% acetonitrile + 0.1% formic acid)
as negative control, with cell lysis buffer as positive con-
trol or with Pam (Fig. 6C). While cell vitality was unal-
tered in the presence of HPLC solvent (100  10.51%
vital cells; P = 0.89), incubation with Pam led to a signifi-
cant decrease in cell vitality (12.86  11.91% vital cells;
P = 0.0024, Student’s t-test) after 40 h comparable to the
effect of cell lysis buffer (4.01  0.22% vital cells;
P = 0.0008, Student’s t-test). These results suggested that
in addition to its antibacterial and antifungal activity,
Pam also is cytotoxic to insect cells.
Biosynthesis gene clusters containing genes coding for
homologs of XcnA and XcnG are described to be
evolutionary conserved (Reimer et al. 2011). Among these
clusters is the biosynthesis gene cluster leading to the
production of colibactin (Homburg et al. 2007; Reimer
et al. 2011). The polyketide-peptide hybrid colibactin,
produced by strains of Escherichia coli harboring a
genomic island called “pks,” has been described as cyto-
toxin or, more precisely, as genotoxin (Nougayrede et al.
2006; Cuevas-Ramosa et al. 2010). However, insect cells
intoxicated by Pam did not show the cytopathic effect
described for colibactin, i.e., megalocytosis, characterized
by a progressive enlargement of the cell body and nucleus
and the absence of mitosis, indicating that cytotoxicity of
Pam is different from colibactin’s effect on eukaryotic
cells.
Paenilamicin is involved in the time course
of infection
Based on the in vitro cytotoxic activity of purified Pam
against insect cells we hypothesized that Pam might act as
toxin during P. larvae infection. To test this assumption
we performed exposure bioassays with wild-type P. larvae
(DSM25430 wt) and the mutant strain lacking Pam
(A) (B)
(C)
Figure 6. Antibacterial, antifungal, and cytotoxic activity of purified paenilamicin. (A) Isolated paenilamicin (left column) showed antibiotic activity
against B. megaterium, B. licheniformis, P. alvei, P. pastoris, and F. oxyporum. HPLC solvent served as negative control. (B) Increasing
concentrations of purified paenilamicin were tested in agar diffusion assays against B. megaterium (0.3–20.0 lg Pam) and F. oxysporum (5.0–
40.0 lg Pam) as bacterial and fungal indicator strain, respectively. Water was used as a control. (C) Tn5 cells were incubated for 40 h in cell
culture medium (SF900 II) or in cell culture medium supplemented with HPLC solvent as negative control, cell lysis buffer as positive control, and
paenilamicin isolated from DSM25430 wt. Quantitative measure of cell vitality obtained by the MTT test is shown in the bar graph. Cells
incubated with paenilamicin showed a significantly decreased vitality compared to the two negative controls. Bars represent mean values  SD of
three replicates, analyzed by Student’s t-test (**P < 0.01). HPLC, high-pressure liquid chromatography.
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production (DSM25430 ΔpamA). Surprisingly, total mor-
tality did not differ significantly between the groups
infected with wild-type or mutant bacteria (Fig. 7A). This
result did not corroborate a function of Pam as toxin
during infection despite its cytotoxicity in vitro and exem-
plified that in the P. larvae/honey bee larvae system it is
obviously not always possible to infer from in vitro data
on in vivo function.
Analyzing the time course of infection revealed that the
curve for cumulative mortality was shifted to the right for
the groups infected with the mutant strain (Fig. 7B) indi-
cating that in these groups the onset of larval dying was
significantly delayed in comparison to the groups infected
with wild-type bacteria (P = 0.028; two-way ANOVA).
Accordingly, the LT100 also significantly differed between
both strains (Student’s t-test, P = 0.0142). The wild-type
strain DSM25430 needed 8.33  1.52 days to kill all
infected larvae, whereas it took the mutant strain
DSM25430 ΔpamA 12.0  0 days to accomplish killing
all infected animals. These results suggested that Pam
although not influencing total mortality influenced the
time course of disease and, hence, can be considered a
virulence factor.
These assays were all performed with P. larvae
DSM25430, a strain belonging to the genotype ERIC II,
and a mutant thereof. So far, no toxin genes could be
identified in this genotype (F€unfhaus et al. 2009; Djukic
et al. 2014) while two functional AB toxins, Plx1 and
Plx2, have been characterized in P. larvae ERIC I quite
recently (F€unfhaus et al. 2013). Gene disruption in these
toxin genes led to a significant reduction in mortality
indicating that they are virulence factors and play an
important role during pathogenesis (F€unfhaus et al.
2013). If the function of Pam were to act as cytotoxin
during infection and to help breaching the epithelial cell
layer (Yue et al. 2008) we would have expected a similar
significant reduction in total mortality in the absence of
this toxin, especially because so far no toxin gene has
been identified in this strain (Djukic et al. 2014).
Instead, absence or presence of Pam production did not
make a difference in total mortality but instead a delay
in the onset of larval dying was observed in those larvae
that were infected with the mutant bacteria. This sug-
gested that Pam might play a role in the very early
phase of infection when P. larvae germinates and starts
to colonize the larval midgut. However, the observed
effect caused by the absence of Pam cannot simply be
explained by differences in germination efficiency
between the wild-type and the mutant strains. Both, ger-
mination and growth of the mutant strain were not neg-
atively influenced in cultured P. larvae when compared
to the wild-type strain (Fig. 1) and all larvae were
infected with the same concentration of CFUs, hence,
with the same concentration of germinating spores.
Therefore, more experimental work is necessary to unra-
vel the exact function of Pam in pathogenesis of P. lar-
vae infections and to explain its influence on virulence
of P. larvae.
In summary, we here presented the identification,
isolation, and biological characterization of Pam, a pep-
tide-polyketide hybrid produced by the bacterial honey
bee pathogen P. larvae. We were able to prove that Pam
which consists of two components with molecular masses
of [M+H]+ = 1009.6718 and 1037.6780 Da has antibacte-
rial and antifungal activity. In addition, we demonstrated
that paenilamcin has cytotoxic activity against insect cells,
although a function as toxin during P. larvae infection of





























Figure 7. Role of paenilamicin during infection of honey bee larvae.
(A) First instar honey bee larvae were infected with P. larvae
DSM25430 wt and DSM25430 ΔpamA. Daily mortality due to
P. larvae infection was recorded and total mortality was calculated.
Bars represent the percentage of exposed larvae that died from
American Foulbrood after 15 days. Bars represent mean values  SD
of three independent exposure bioassays each with three groups
(control, wt and mutant bacteria) and 30 larvae per group. Data were
analyzed by Student0s t-test. No significant difference in total
mortality was observed. (B) Daily mortality due to P. larvae infection
was recorded and cumulative mortality was calculated. Larvae
infected with DSM25430 ΔpamA died as fast as larvae that had been
infected with wild-type bacteria, however, onset of larval dying was
delayed resulting in a significant parallel shift of the cumulative
mortality curve to the right. Curves represent mean cumulative
mortality  SD for each day of three replicas with 30 larvae each.
Data were analyzed by two-way ANOVA (P = 0.028).
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larvae infected by P. larvae lacking Pam production a
delayed onset of larval mortality by unaltered total mor-
tality could be observed in comparison to larvae infected
by wild-type bacteria. These results suggested that Pam is
involved in determining the time course of disease and,
hence, can be considered a virulence factor of P. larvae.
Further experimental work is necessary to elucidate the
chemical structures of Pam as well as mechanistic details
of Pam activity during AFB pathogenesis which will
finally unravel the full potential of this secondary
metabolite.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Comparison of LC-ESI-Orbitrap-MS profiling
of metabolites present in the crude supernatant. (A) Total
ion chromatogram (TIC) of P. larvae DSM25430 wt and
(B) total ion chromatogram (TIC) of P. larvae DSM25430
ΔpamA. Paenilamicin could not be detected directly from
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crude supernatants due to early elution in the dead volume
and ion suppression. The secondary metabolite sevadicin is
indicated with a red arrow.
Figure S2. MS/MS fragmentation studies on paenilamicin
by HPLC-ESI-triple quadrupole MS from P. larvae
secretome after sample workup. (A) MS/MS fragmenta-
tion spectrum with [M + 2H]2+ = 505.4 as precursor
ion (♦). (B) MS/MS fragmentation spectrum with
[M + 2H]2+ = 519.4 as precursor ion (♦).
Figure S3. HPLC UV analytics of pure paenilamicin. (A)
Chromatogram of pure paenilamicin monitored at
k = 214 nm. (B) Chromatogram of a blank measurement
(H2O) monitored at k = 214 nm. Paenilamicin shows
practically no retention at the C18 column.
Table S1. Homology analysis of the pam gene cluster
products.
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